Identification of PIK3C3 promoter variant associated with bipolar disorder and schizophrenia
暂无分享,去创建一个
Pavla Stopkova | H. Lachman | P. Stopkova | R. Strous | D. Papolos | Rael D Strous | Takuya Saito | J. Vevera | Herbert M Lachman | Takuya Saito | Demitri F Papolos | Jan Vevera | Ivo Paclt | Ilja Zukov | Yonina B Bersson | Benjamin A Margolis | I. Paclt | I. Žukov | Benjamin Margolis | Yonina B. Bersson | B. Margolis | P. Stopková
[1] P. Camilli,et al. A presynaptic inositol-5-phosphatase , 1996, Nature.
[2] W. Herr,et al. The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. , 1995, Genes & development.
[3] J. Kelsoe,et al. Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder , 2003, Molecular Psychiatry.
[4] Kari Stefansson,et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. , 2003, American journal of human genetics.
[5] E. Robins,et al. Research diagnostic criteria. , 1975, Psychopharmacology bulletin.
[6] T. Crow,et al. A genome-wide search for schizophrenia susceptibility genes. , 1998, American journal of medical genetics.
[7] J. Nurnberger,et al. Chromosome 6 workshop report. , 1999, American journal of medical genetics.
[8] Henrik Ewald,et al. Search for a shared segment on chromosome 10q26 in patients with bipolar affective disorder or schizophrenia from the Faroe Islands. , 2002, American journal of medical genetics.
[9] D. Latchman,et al. POU family transcription factors in the nervous system , 1999, Journal of cellular physiology.
[10] L. Pirola,et al. Structure and function of phosphoinositide 3-kinases. , 1998, Biochimica et biophysica acta.
[11] P. Camilli,et al. PIP Kinase Iγ Is the Major PI(4,5)P2 Synthesizing Enzyme at the Synapse , 2001, Neuron.
[12] John P. Rice,et al. Suggestive evidence of a locus on chromosome 10p using the NIMH genetics initiative bipolar affective disorder pedigrees. , 2000, American journal of medical genetics.
[13] P. De Camilli,et al. Phosphoinositides in membrane traffic at the synapse. , 2001, Journal of cell science.
[14] Lei Zhang,et al. Cyclin-dependent Kinase-5 Is Involved in Neuregulin-dependent Activation of Phosphatidylinositol 3-Kinase and Akt Activity Mediating Neuronal Survival* , 2003, Journal of Biological Chemistry.
[15] T. Matise,et al. Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium. , 1998, American journal of medical genetics.
[16] H. Stefánsson,et al. Neuregulin 1 and susceptibility to schizophrenia. , 2002, American journal of human genetics.
[17] C. Dion,et al. A search for specific and common susceptibility loci for schizophrenia and bipolar disorder: a linkage study in 13 target chromosomes , 2001, Molecular Psychiatry.
[18] F. McMahon,et al. Initial genome scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 1, 6, 8, 10, and 12. , 1997, American journal of medical genetics.
[19] Graham L. Collingridge,et al. Phosphatidylinositol 3 kinase regulates synapse specificity of hippocampal long-term depression , 2002, Nature Neuroscience.
[20] E. Nestler,et al. Chronic electroconvulsive seizure (ECS) treatment results in expression of a long-lasting AP-1 complex in brain with altered composition and characteristics , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[21] R. Lenox,et al. Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks , 2003, Molecular Psychiatry.
[22] G. Moore,et al. Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilisers , 2001, British Journal of Psychiatry.
[23] J. Kelsoe,et al. Linkage studies suggest a possible locus for bipolar disorder near the velo-cardio-facial syndrome region on chromosome 22. , 1997, American journal of medical genetics.
[24] E. Robins,et al. Research diagnostic criteria: rationale and reliability. , 1978, Archives of general psychiatry.
[25] R. MacQuarrie,et al. Lithium Effects on Inositol Phospholipids and Inositol Phosphates: Evaluation of an In Vivo Model for Assessing Polyphosphoinositide Turnover in Brain , 1992, Journal of neurochemistry.
[26] M. Rosenfeld,et al. A two-base change in a POU factor-binding site switches pituitary-specific to lymphoid-specific gene expression. , 1990, Genes & development.
[27] M. Rietschel,et al. Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by nonparametric linkage analysis. , 1998, American journal of medical genetics.
[28] M. Chao,et al. Differential association of phosphatidylinositol-5-phosphate 4-kinase with the EGF/ErbB family of receptors. , 1999, Cellular signalling.
[29] N. Freimer,et al. Genome screening for linkage disequilibrium in a Costa Rican sample of patients with bipolar-I disorder: a follow-up study on chromosome 18. , 2001, American journal of medical genetics.
[30] Feng Yang,et al. PI-3 kinase and IP3 are both necessary and sufficient to mediate NT3-induced synaptic potentiation , 2001, Nature Neuroscience.
[31] G. Prestwich,et al. A Pleckstrin Homology Domain Specific for Phosphatidylinositol 4,5-Bisphosphate (PtdIns-4,5-P2) and Fused to Green Fluorescent Protein Identifies Plasma Membrane PtdIns-4,5-P2 as Being Important in Exocytosis* , 2000, Journal of Biological Chemistry.
[32] J. Dixon,et al. The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[33] M. Ciesielski,et al. Evaluation of Systemically Administered Radiolabeled Epidermal growth Factor as a Brain Tumor Targeting Agent , 2001, Journal of Neuro-Oncology.
[34] P. Holmans,et al. Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III. , 2000, American journal of human genetics.
[35] L R Goldin,et al. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[36] B. Luisi,et al. The virtuoso of versatility: POU proteins that flex to fit. , 2000, Journal of molecular biology.
[37] H. N. Freeman,et al. Phosphorylation of a Synaptic Vesicle-associated Protein by an Inositol Hexakisphosphate-regulated Protein Kinase* , 2001, The Journal of Biological Chemistry.
[38] Y. Nishizuka. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. , 1992, Science.
[39] J. Brady,et al. The class III POU factor Brn-4 interacts with other class III POU factors and the heterogeneous nuclear ribonucleoprotein U. , 1997, Brain research. Molecular brain research.
[40] F. Zhao,et al. Involvement of Oct-1 in transcriptional regulation of beta-casein gene expression in mouse mammary gland. , 2002, Biochimica et biophysica acta.
[41] M. Gladis,et al. Second stage of a genome scan of schizophrenia: study of five positive regions in an expanded sample. , 2000, American journal of medical genetics.
[42] J. Nurnberger,et al. Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[43] M. Klein,et al. Mutation analysis of SYNJ1: a possible candidate gene for chromosome 21q22-linked bipolar disorder , 2001, Molecular Psychiatry.
[44] M. Boehnke,et al. Examination of genetic linkage of chromosome 15 to schizophrenia in a large Veterans Affairs Cooperative Study sample. , 2001, American journal of medical genetics.
[45] W. Honer,et al. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. , 2000, Science.
[46] D. Melton,et al. A molecular mechanism for the effect of lithium on development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[47] L. Siever,et al. Genome scan of schizophrenia , 1998 .
[48] Michael J. Berridge,et al. Inositol phosphates and cell signalling , 1989, Nature.
[49] J S Sinsheimer,et al. Chromosome 1 loci in Finnish schizophrenia families. , 2001, Human molecular genetics.
[50] J. Williamson,et al. Formation and metabolism of inositol 1,3,4,5-tetrakisphosphate in liver. , 1986, The Journal of biological chemistry.
[51] O. Mors,et al. Susceptibility loci for bipolar affective disorder on chromosome 18? A review and a study of Danish families , 1997, Psychiatric genetics.
[52] C. Beasley,et al. Expression of Oct-6, a POU III domain transcription factor, in schizophrenia. , 2002, The American journal of psychiatry.
[53] H. Lachman,et al. Polymorphism Screening of PIP5K2A: A Candidate Gene for Chromosome 10p‐Linked Psychiatric Disorders , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[54] Richard A. Firtel,et al. Leading the way: directional sensing through phosphatidylinositol 3-kinase and other signaling pathways , 2003, Journal of Cell Science.
[55] D. Eberhard,et al. Evidence that the inositol phospholipids are necessary for exocytosis. Loss of inositol phospholipids and inhibition of secretion in permeabilized cells caused by a bacterial phospholipase C and removal of ATP. , 1990, The Biochemical journal.
[56] Y. Okubo,et al. Evidence for association of the myo-inositol monophosphatase 2 (IMPA2) gene with schizophrenia in Japanese samples , 2001, Molecular Psychiatry.
[57] R. Jope,et al. Mood stabilizers, glycogen synthase kinase-3β and cell survival , 2002, Molecular Psychiatry.
[58] A. Toker,et al. Signalling through the lipid products of phosphoinositide-3-OH kinase , 1997, Nature.
[59] W. Berrettini,et al. Are schizophrenic and bipolar disorders related? A review of family and molecular studies , 2000, Biological Psychiatry.
[60] T. Matise,et al. Suggestive linkage of chromosome 10p to schizophrenia is not due to transmission ratio distortion. , 1999, American journal of medical genetics.
[61] H. Kobayashi,et al. Roles of synaptotagmin C2 domains in neurotransmitter secretion and inositol high-polyphosphate binding at mammalian cholinergic synapses. , 1997, Neuroscience.
[62] M. Caron,et al. Agonist-dependent Recruitment of Phosphoinositide 3-Kinase to the Membrane by β-Adrenergic Receptor Kinase 1 , 2001, The Journal of Biological Chemistry.
[63] P. Schofield,et al. A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 as well as chromosomes 9, 13 and 19 , 2002, Molecular Psychiatry.
[64] Jurg Ott,et al. A possible vulnerability locus for bipolar affective disorder on chromosome 21q22.3 , 1994, Nature Genetics.
[65] N. Schork,et al. A genome-wide search for chromosomal loci linked to mental health wellness in relatives at high risk for bipolar affective disorder among the Old Order Amish. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[66] S. García-Silva,et al. An Element in the Region Responsible for Premature Termination of Transcription Mediates Repression of c-myc Gene Expression by Thyroid Hormone in Neuroblastoma Cells* , 2000, The Journal of Biological Chemistry.
[67] T. Sekiya,et al. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[68] M. Caron,et al. Phosphoinositide 3-kinase regulates β2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/β-arrestin complex , 2002, The Journal of cell biology.
[69] P. Sharp,et al. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes , 1986, Nature.
[70] J. Endicott,et al. A diagnostic interview: the schedule for affective disorders and schizophrenia. , 1978, Archives of general psychiatry.
[71] P. Gean,et al. A Role for the PI-3 Kinase Signaling Pathway in Fear Conditioning and Synaptic Plasticity in the Amygdala , 2001, Neuron.
[72] R. Straub,et al. A schizophrenia locus may be located in region 10p15-p11. , 1998, American journal of medical genetics.
[73] R. Jope,et al. Effects of chronic lithium treatment on protein kinase c and cyclic AMP-dependent protein phosphorylation , 1991, Biological Psychiatry.
[74] W. Sherman,et al. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. , 1980, The Journal of biological chemistry.